Evidence map›Paper›PMID 35868275›Full record

ReviewCell2022

Synthetic chromosomes, genomes, viruses, and cells.

J Craig Venter, John I Glass, Clyde A Hutchison, Sanjay Vashee

Abstract readReview
In one paragraph

Review in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. CGC1, a new reference genome forGenome research · 2025
    Article
  17. The design and engineering of synthetic genomes.Nature reviews. Genetics · 2025
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J Craig VenterThe J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA. Electronic address: jcventer@jcvi.org.
John I GlassThe J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA.
Clyde A HutchisonThe J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA.
Sanjay VasheeThe J. Craig Venter Institute, La Jolla, CA, and Rockville, MD, USA.

Funding

Elucidation of genetic networks of HSV-1 virion proteins and discovery of their functions in the morphogenesis of the infectious virus particleR01AI137365 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DESAI, PRASHANT J, VASHEE, SANJAY · 2019 to 2024
$3.2M
Development of FRESH (Fast Rescue Employing Self-Helper virus) - a rapid, generalizable method to rescue infectious virus from noninfectious genomic materialR21AI149448 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI VASHEE, SANJAY · 2020 to 2021
$536k
Synthetic Genomics to Improve a Phage-Based Diagnostic for Multi-Drug Resistant BacteriaR21AI146703 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI VASHEE, SANJAY · 2019 to 2020
$516k
Synthetic Genomics Approach to Assemble Infectious Clones of KSHVR03AI146632 · NIAID · JOHNS HOPKINS UNIVERSITY · PI DESAI, PRASHANT J, VASHEE, SANJAY · 2019 to 2020
$195k
NIAID NIH HHS R01 AI137365NIAID NIH HHS R03 AI146632NIAID NIH HHS R21 AI146703NIAID NIH HHS R21 AI149448
6 · The paper itself

Abstract

Synthetic genomics is the construction of viruses, bacteria, and eukaryotic cells with synthetic genomes. It involves two basic processes: synthesis of complete genomes or chromosomes and booting up of those synthetic nucleic acids to make viruses or living cells. The first synthetic genomics efforts resulted in the construction of viruses. This led to a revolution in viral reverse genetics and improvements in vaccine design and manufacture. The first bacterium with a synthetic genome led to construction of a minimal bacterial cell and recoded Escherichia coli strains able to incorporate multiple non-standard amino acids in proteins and resistant to phage infection. Further advances led to a yeast strain with a synthetic genome and new approaches for animal and plant artificial chromosomes. On the horizon there are dramatic advances in DNA synthesis that will enable extraordinary new opportunities in medicine, industry, agriculture, and research.

Indexed as

BacteriophagesChromosomesAnimalsEscherichia coliGenome, ViralGenomicsSaccharomyces cerevisiaeSequence Analysis, DNASynthetic Biology

Identifiers

PMID35868275
PMCPMC9347161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.